Join Aldevron and Trince for an exclusive half-day seminar highlighting the latest tools for non-viral CRISPR and mRNA processes. Learn more about innovations in non‑viral cell engineering at this Lunch & Learn event.

Learn how top-tier upstream DNA and RNA technologies, paired with next-gen non-viral delivery methods, can expedite your research and development efforts, particularly with challenging cell types. This in-person gathering is designed for scientists, developers, and innovators who are leaders in cell and gene therapy, offering plenty of opportunities for discussion, Q&A, and networking. 

Lunch and refreshments are provided.

What to expect:

  • Insightful presentations from keynote speakers at NecstGen/NKI, sharing practical viewpoints on the development of advanced cell and gene therapies.
  • An exploration of Aldevron’s offerings for non-viral processes, such as Nanoplasmid™ vector technology or Codex® HiCap RNA T7 Polymerase.
  • A presentation from Trince regarding its photoporation-based transfection technology, highlighting how integrating LumiPore® delivery with Aldevron’s Nanoplasmid can improve non-viral delivery to hard-to-transfect cell types.
  • Opportunities …

Learn how top-tier upstream DNA and RNA technologies, paired with next-gen non-viral delivery methods, can expedite your research and development efforts, particularly with challenging cell types. This in-person gathering is designed for scientists, developers, and innovators who are leaders in cell and gene therapy, offering plenty of opportunities for discussion, Q&A, and networking. 

Lunch and refreshments are provided.

What to expect:

  • Insightful presentations from keynote speakers at NecstGen/NKI, sharing practical viewpoints on the development of advanced cell and gene therapies.
  • An exploration of Aldevron’s offerings for non-viral processes, such as Nanoplasmid™ vector technology or Codex® HiCap RNA T7 Polymerase.
  • A presentation from Trince regarding its photoporation-based transfection technology, highlighting how integrating LumiPore® delivery with Aldevron’s Nanoplasmid can improve non-viral delivery to hard-to-transfect cell types.
  • Opportunities to connect with fellow professionals from academia, biotech, and translational research in dedicated networking sessions.

Come to Lunch & Learn how Aldevron can assist you in maximising the potential of your projects.

When

  • Tuesday the 26th of may 2026 from 08:45 to 13:00

Location